MITAKY
MITAKY is a Japanese technology company.
Q1. What is immune cell therapy?
“Immune cell therapy is a treatment that extracts, activates, and reinfuses a patient’s immune cells to strengthen their ability to recognize and destroy cancer cells.”
View in the company profileQ2. Is immune cell therapy safe?
“Yes, immune cell therapy is generally safe because it uses the patient’s own immune cells, which eliminates the risk of rejection or severe allergic reactions. The procedures involved, such as blood collection and reinfusion, are minimally invasive.”
View in the company profileQ3. How does immune cell therapy work?
“The therapy boosts the immune system by activating and expanding immune cells like T cells and NK cells, which target and destroy cancer cells more effectively.”
View in the company profileQ4. What types of cancer can immune cell therapy treat?
“This therapy is effective for cancers such as lung, breast, colorectal, ovarian, pancreatic, liver, gastric, prostate cancers, and rare cancers like thymus and bone cancer.”
View in the company profileQ5. What are the side effects of immune cell therapy?
“Side effects are typically rare and may include fever, fatigue, or temporary inflammation at the injection site.”
View in the company profileQ6. How is immune cell therapy different from chemotherapy or radiation?
“Unlike chemotherapy or radiation, immune cell therapy enhances the body’s natural defenses, minimising damage to healthy cells and reducing side effects.”
View in the company profileQ7. Can immune cell therapy be combined with other treatments?
“Yes, it complements surgery, chemotherapy, or radiotherapy, enhancing overall treatment effectiveness and improving quality of life.”
View in the company profile